Critical Care

official impact factor 4.60
Search for
Advanced search
Critical Care
Tools
Share this article
Open Access Highly Access

Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated)

Andrew F Shorr*, Jonathan M Janes, Antonio Artigas, Jyrki Tenhunen, Duncan LA Wyncoll, Emmanuelle Mercier, Bruno Francois, Jean-Louis Vincent, Burkhard Vangerow, Darell Heiselman, Amy G Leishman, Yajun E Zhu, Konrad Reinhart and the RESPOND investigators

Critical Care 2010, 14:R229 doi:10.1186/cc9382


See related commentary by Levi, http://ccforum.com/content/15/1/105

Accesses  

  • Last 30 days: 67 accesses
  • Last 365 days: 1237 accesses
  • All time: 3806 accesses

Cited by

BioMed Central: 2 citations

Research   Open Access Highly Accessed

Nebulized anticoagulants for acute lung injury - a systematic review of preclinical and clinical investigations

Pieter R Tuinman, Barry Dixon, Marcel Levi, Nicole P Juffermans, Marcus J Schultz Critical Care 2012, 16:R70 (30 April 2012)

Abstract | Full text | PDF | PubMed

Commentary   Free

Treatment with recombinant human activated protein C: one size does not fit all

Marcel Levi Critical Care 2010, 15:105 (17 January 2011)

Abstract | Full text | PDF

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations